X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Merck Ltd with ASTRAZENECA PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MERCK LTD vs ASTRAZENECA PHARMA - Comparison Results

MERCK LTD    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

ASTRAZENECA PHARMA 
   Change

AstraZeneca Pharma India Limited (APIL) is a 90% subsidiary of the UK based AstraZeneca Pharmaceuticals, which is one of the world's leading pharma companies. APIL has interests in the six crucial areas of cardiovascular, respiratory, maternal health... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MERCK LTD ASTRAZENECA PHARMA MERCK LTD/
ASTRAZENECA PHARMA
 
P/E (TTM) x 34.1 106.4 32.0% View Chart
P/BV x 3.8 15.2 25.2% View Chart
Dividend Yield % 0.7 0.0 -  

Financials

 MERCK LTD   ASTRAZENECA PHARMA
EQUITY SHARE DATA
    MERCK LTD
Dec-16
ASTRAZENECA PHARMA
Mar-14
MERCK LTD/
ASTRAZENECA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,0601,285 82.5%   
Low Rs623634 98.3%   
Sales per share (Unadj.) Rs632.4189.6 333.6%  
Earnings per share (Unadj.) Rs45.7-0.2 -22,454.3%  
Cash flow per share (Unadj.) Rs62.33.8 1,620.9%  
Dividends per share (Unadj.) Rs11.000-  
Dividend yield (eoy) %1.30-  
Book value per share (Unadj.) Rs388.868.6 566.5%  
Shares outstanding (eoy) m16.6025.00 66.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.35.1 26.3%   
Avg P/E ratio x18.4-4,712.7 -0.4%  
P/CF ratio (eoy) x13.5249.6 5.4%  
Price / Book Value ratio x2.214.0 15.5%  
Dividend payout %24.10-   
Avg Mkt Cap Rs m13,96923,988 58.2%   
No. of employees `0001.61.6 101.5%   
Total wages/salary Rs m1,4871,605 92.7%   
Avg. sales/employee Rs Th6,631.93,040.2 218.1%   
Avg. wages/employee Rs Th939.21,029.2 91.2%   
Avg. net profit/employee Rs Th479.4-3.3 -14,683.6%   
INCOME DATA
Net Sales Rs m10,4984,740 221.5%  
Other income Rs m24292 263.2%   
Total revenues Rs m10,7414,832 222.3%   
Gross profit Rs m1,135-130 -874.7%  
Depreciation Rs m276101 272.2%   
Interest Rs m00-   
Profit before tax Rs m1,102-139 -793.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0139 0.0%   
Tax Rs m3435 6,744.6%   
Profit after tax Rs m759-5 -14,909.6%  
Gross profit margin %10.8-2.7 -394.9%  
Effective tax rate %31.1-3.7 -850.0%   
Net profit margin %7.2-0.1 -6,731.3%  
BALANCE SHEET DATA
Current assets Rs m6,4102,726 235.1%   
Current liabilities Rs m8,8282,435 362.6%   
Net working cap to sales %-23.06.1 -374.8%  
Current ratio x0.71.1 64.8%  
Inventory Days Days5874 78.2%  
Debtors Days Days3841 94.2%  
Net fixed assets Rs m1,4061,035 135.8%   
Share capital Rs m16650 332.0%   
"Free" reserves Rs m6,286942 667.0%   
Net worth Rs m6,4551,716 376.1%   
Long term debt Rs m00-   
Total assets Rs m8,8284,156 212.4%  
Interest coverage xNMNM-  
Debt to equity ratio x00-  
Sales to assets ratio x1.21.1 104.3%   
Return on assets %8.6-0.1 -7,018.8%  
Return on equity %11.8-0.3 -3,963.8%  
Return on capital %17.10-  
Exports to sales %8.35.7 145.3%   
Imports to sales %21.06.5 325.6%   
Exports (fob) Rs m869270 321.8%   
Imports (cif) Rs m2,209306 721.3%   
Fx inflow Rs m959375 256.0%   
Fx outflow Rs m2,612470 555.6%   
Net fx Rs m-1,653-96 1,730.2%   
CASH FLOW
From Operations Rs m1,070-8 -13,214.8%  
From Investments Rs m-750-146 514.6%  
From Financial Activity Rs m-150862 -17.4%  
Net Cashflow Rs m171709 24.1%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 51.8 75.0 69.1%  
Indian inst/Mut Fund % 18.2 0.3 6,066.7%  
FIIs % 1.0 15.7 6.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 9.1 319.8%  
Shareholders   28,591 12,856 222.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MERCK LTD With:   PANACEA BIOTECH  DISHMAN PHARMA  TTK HEALTHCARE  NATCO PHARMA  DIVIS LABORATORIES  

Compare MERCK LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades in Red; PSU & Energy Stocks Decline(01:30 pm)

Indian share markets continued to trade in red during the noon session weak Asian markets. PSU stocks and energy stocks are witnessing majority of the selling activity.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

MERCK LTD SHARE PRICE


Feb 22, 2018 02:31 PM

TRACK MERCK LTD

  • Track your investment in MERCK LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MERCK LTD 8-QTR ANALYSIS

COMPARE MERCK LTD WITH

MARKET STATS